In vitro selection and analysis of human immunodeficiency virus Type 1 resistant to derivatives of β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

被引：13

作者：

Hammond, JL

Parikh, UM

Koontz, DL

Schlueter-Wirtz, S

Chu, CK

Bazmi, HZ

Schinazi, RF

Mellors, JW

机构：

[1] Univ Pittsburgh, Sch Med, Div Infect Dis, Dept Med, Pittsburgh, PA 15261 USA

[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA

[3] Vet Affairs Med Ctr, Georgia VA Res Ctr AIDS & HIV Infect, Atlanta, GA 30033 USA

[4] Univ Georgia, Coll Pharm, Athens, GA 30602 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 09期

关键词：

D O I：

10.1128/AAC.49.9.3930-3932.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Serial passage of human immunodeficiency virus type 1 in MT-2 cells in increasing concentrations of the D-and L-enantiomers of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine (d4FC) resulted in the selection of viral variants with reverse transcriptase substitutions M184I or M184V for L-d4FC and I63L, K65R, K70N, K70E, or R172K for D-d4FC. Phenotypic analysis of site-directed mutants defined the role of these mutations in reducing susceptibility to L- or D-d4FC.

引用

页码：3930 / 3932

页数：3

共 50 条

[21] Interaction of β-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases:: Implications for human immunodeficiency virus drug design
Kukhanova, M
Li, XY
Chen, SH
King, I
Doyle, T
Prusoff, W
Cheng, YC
MOLECULAR PHARMACOLOGY, 1998, 53 (05) : 801 - 807
[22] SELECTIVE ACTION OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE TRIPHOSPHATE ON HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AND HUMAN DNA-POLYMERASES
HUANG, P
FARQUHAR, D
PLUNKETT, W
JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (04) : 2817 - 2822
[23] Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine
Zhu, YQ
Remington, KM
North, TW
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 1983 - 1987
[24] DIFFERENTIAL PATTERNS OF INTRACELLULAR METABOLISM OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE AND 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE, 2 POTENT ANTI-HUMAN IMMUNODEFICIENCY VIRUS COMPOUNDS
BALZARINI, J
HERDEWIJN, P
DECLERCQ, E
JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (11) : 6127 - 6133
[25] SYNTHESIS OF 2',3'-DIDEHYDRO-2',3'-DIDEOXY-2'-C- METHYLSUBSTITUTED NUCLEOSIDES USING A NOVEL SN2' TYPE REACTION
IONNIDIS, P
CLASSON, B
SAMUELSSON, B
KVARNSTROM, I
NUCLEOSIDES & NUCLEOTIDES, 1993, 12 (05): : 449 - 462
[26] Synthesis and anti-HIV-1 evaluation of phosphonates which mimic the 5′-monophosphate of 4′-branched 2′,3′-didehydro-2′,3′-dideoxy nucleosides
Kubota, Yutaka
Ishizaki, Nobuhide
Haraguchi, Kazuhiro
Hamasaki, Takayuki
Baba, Masanori
Tanaka, Hiromichi
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (20) : 7186 - 7192
[27] DNA CHAIN TERMINATION ACTIVITY AND INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY CARBOCYCLIC 2',3'-DIDEHYDRO-2',3'-DIDEOXYGUANOSINE TRIPHOSPHATE
ORR, DC
FIGUEIREDO, HT
MO, CL
PENN, CR
CAMERON, JM
JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (06) : 4177 - 4182
[28] Synthesis and evaluation of 5-halo 2',3'-didehydro-2',3'-dideoxynucleosides and their blocked phosphoramidates as potential anti-human immunodeficiency virus agents: an example of 'kinase bypass'
McGuigan, C
Velazquez, S
DeClercq, E
Balzarini, J
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06): : 519 - 527
[29] In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-fluoro-2',3'-dideoxyadenosine
Tanaka, M
Srinivas, RV
Ueno, T
Kavlick, MF
Hui, FK
Fridland, A
Driscoll, JS
Mitsuya, H
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1313 - 1318
[30] ANTIVIRAL ACTIVITY OF 2',3'-DIDEOXY-BETA-L-5-FLUOROCYTIDINE (BETA-L-FDDC) AND 2',3'-DIDEOXY-BETA-L-CYTIDINE (BETA-L-DDC) AGAINST HEPATITIS-B VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO
LIN, TS
LUO, MZ
LIU, MC
PAI, SB
DUTSCHMAN, GE
CHENG, YC
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) : 171 - 174

← 1 2 3 4 5 →